PeRfusiOn Post tHrombEcTomy (PROPHET)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

Endovascular mechanical thrombectomy is the standard of care for treating patients with a large-vessel occlusion acute ischemic stroke. However, in more than half of these patients, remaining distal vessel occlusions limit the benefit of this therapy. Currently the detection of residual vessel occlusions and the decision for further treatment by the operator is based on the 2D digital subtraction angiography (DSA) images. However, this technique has several limitations. Recently, a new imaging technique, with the possibility to acquire 3D time-resolved perfusion images directly in the operating room was introduced (the flat-panel detector computed tomography perfusion imaging, FDCTP). It can overcome the spatial limitations of 2D DSA, but the details on clinical validation and utility of FDCTP are currently lacking.

Eligibility criteria

Qualifiers

Informed consent as documented by a signature

The patients received mechanical thrombectomy or there was the intention to perform endovascular treatment, but only diagnostic angiography was performed.

Patients received FDCTP as clinically indicated by the treating physician.

Disqualifiers

Inability to give consent due to insufficient knowledge of the project language

Inability to follow the clinically indicated visit at 90 days after the index stroke (e.g. patients living abroad).

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

279 Participants
are grouped into 1 trial group